Lamotrigine is a phenyltriazine anticonvulsant and mood stabilizer primarily used to treat epilepsy and manage bipolar I disorder. It functions by inhibiting voltage-gated sodium channels and modulating… Read more
















![Chemical structure of 2-[(2,4-Dichlorophenyl)-cyanomethylene]-hydrazine Carboximidamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F94266-27-0-2-24-Dichlorophenyl-cyanomethylene-hydrazine-Carboximidamide.png&w=3840&q=75)
![Chemical structure of 2-[(3,4-Dichlorophenyl)-cyanomethylene]-hydrazine Carboximidamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F356757-50-1-2-34-Dichlorophenyl-cyanomethylene-hydrazine-Carboximidamide.png&w=3840&q=75)
































Lamotrigine is a phenyltriazine anticonvulsant and mood stabilizer primarily used to treat epilepsy and manage bipolar I disorder. It functions by inhibiting voltage-gated sodium channels and modulating the release of excitatory neurotransmitters like glutamate to stabilize neuronal membranes. This category provides an extensive range of pharmaceutical reference standards, including impurities, degradation products, synthetic intermediates, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing impurity profiling, method validation, and quality control. By utilizing these highly characterized standards, researchers can ensure analytical reliability, maintain regulatory compliance, and support forced degradation studies. Stable isotope labelled compounds, in particular, are frequently employed in advanced analytical techniques like LC-MS/MS for precise quantification. Our collection provides the necessary benchmarks to verify identity, potency, and purity, ensuring the safety and efficacy of medicinal products throughout their development and lifecycle.